52 Week Lows

Portola Pharmaceuticals Inc (NASDAQ: PTLA) shares touched a new 52-week low of $21.92 after announcing Phase III Betrixaban results. Fiesta Restaurant Group Inc (NASDAQ: FRGI) shares touched a new 52-week low of $31.56. Fiesta Restaurant shares have tumbled 48.00 percent over the past 52 weeks,...

Synergy Pharmaceuticals Inc (NASDAQ: SGYP) shares fell 2.70 percent to touch a new 52-week low of $2.52. Synergy Pharmaceuticals shares have dropped 32.20 percent over the past 52 weeks, while the S&P 500 index has declined 1.99 percent in the same period. Vivint Solar Inc (NYSE: VSLR)...

Gordmans Stores, Inc. (NASDAQ: GMAN) shares fell 4.25 percent to touch a new 52-week low of $2.25. Gordmans Stores shares have dropped 57.27 percent over the past 52 weeks, while the S&P 500 index has declined 1.91 percent in the same period. RF Industries, Ltd. (NASDAQ: RFIL) shares fell 3....

Microvision, Inc. (NASDAQ: MVIS) shares fell 12.57 percent to touch a new 52-week low of $1.67. Microvision shares have dropped 49.87 percent over the past 52 weeks, while the S&P 500 index has declined 2.61 percent in the same period. Foresight Energy LP (NYSE: FELP) shares reached a new 52...

Restoration Hardware Holdings Inc (NYSE: RH) shares fell 3.36 percent to touch a new 52-week low of $35.42. Buckingham Research downgraded Restoration Hardware from Neutral to Underperform. Teva Pharmaceutical Industries Ltd (ADR) (NYSE: TEVA) shares fell 0.77 percent to reach a new 52-week low...

Bellicum Pharmaceuticals Inc (NASDAQ: BLCM) shares fell 5.65 percent to touch a new 52-week low of $7.35. Bellicum Pharmaceuticals shares have tumbled 69.92 percent over the past 52 weeks, while the S&P 500 index has declined 3.44 percent in the same period. Vivint Solar Inc (NYSE: VSLR)...

AstraZeneca plc (ADR) (NYSE: AZN) shares touched a new 52-week low of $28.21. AstraZeneca shares have tumbled 19.68 percent over the past 52 weeks, while the S&P 500 index has declined 3.98 percent in the same period. Gain Capital Holdings Inc (NYSE: GCAP) shares touched a new 52-week low of...

Peak Resorts Inc (NASDAQ: SKIS) shares touched a new 52-week low of $2.74 after the company reported weaker-than-expected Q3 results. Osiris Therapeutics, Inc. (NASDAQ: OSIR) shares touched a new 52-week low of $5.11. Osiris Therapeutics shares have tumbled 69.97 percent over the past 52 weeks,...

SCYNEXIS Inc (NASDAQ: SCYX) shares fell 3.61 percent to touch a new 52-week low of $4.01. SCYNEXIS shares have dropped 55.74 percent over the past 52 weeks, while the S&P 500 index has declined 2.83 percent in the same period. Pernix Therapeutics Holdings Inc (NASDAQ: PTX) shares fell 7.60...

Flexion Therapeutics Inc (NASDAQ: FLXN) shares fell 12.26 percent to touch a new 52-week low of $8.52. Flexion reported FY15 loss of $(2.15) per share. Qualstar Corporation (NASDAQ: QBAK) shares fell 4.39 percent to touch a new 52-week low of $0.440. Qualstar shares have tumbled 69.33 percent...

Virtus Investment Partners Inc (NASDAQ: VRTS) shares touched a new 52-week low of $74.49. Jefferies downgraded Virtus Investment Partners from Buy to Hold. Addus Homecare Corporation (NASDAQ: ADUS) shares fell 3.18 percent to touch a new 52-week low of $17.81. Addus Homecare shares have tumbled...

LMI Aerospace, Inc. (NASDAQ: LMIA) shares touched a new 52-week low of $8.33. LMI Aerospace reported a Q4 loss of $0.09 per share on revenue of $89.4 million. Virtus Investment Partners Inc (NASDAQ: VRTS) shares fell 4.03 percent to touch a new 52-week low of $81.02. Virtus Investment Partners...

Federated National Holding Co (NASDAQ: FNHC) shares fell 5.59 percent to touch a new 52-week low of $19.92. Raymond James downgraded Federated National Hldg from Strong Buy to Outperform and lowered the price target from $42.00 to $28.00. Fibria Celulose SA (ADR) (NYSE: FBR) shares fell 10.67...

COMSCORE, Inc. (NASDAQ: SCOR) shares fell 30.66 percent to touch a new 52-week low of $28.23 following announced delay to 10-K filing, cancelled buyback and delayed investor day. Celldex Therapeutics, Inc. (NASDAQ: CLDX) shares touched a new 52-week low of $3.89. Celldex Therapeutics will...

Vitae Pharmaceuticals Inc (NASDAQ: VTAE) shares touched a new 52-week low of $4.27. Vitae Pharmaceuticals reported a Q4 loss $0.52 per share on revenue of $92,000. Stifel Nicolaus downgraded Vitae Pharmaceuticals from Buy to Hold. Tuniu Corp (NASDAQ: TOUR) shares touched a new 52-week low of $8....